» Articles » PMID: 683275

Hyperglucagonemia and Its Suppression. Importance in the Metabolic Control of Diabetes

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1978 Aug 31
PMID 683275
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

The role of glucagon in diabetes was studied in four patients with juvenile-type diabetes during continuous insulin infusion and a diet containing 150 g per day of carbohydrate. During insulin alone, plasma glucagon, measured at two-hour intervals, averaged 182 +/- 34 pg per milliliter, glucose 269 +/- 11 mg per deciliter, glucose excretion 52 +/- 8 g per 24 hours, ketone excretion 1.3 +/- 0.3 mmol per 24 hours, and urea nitrogen 12 +/- 2 g per 24 hours (mean +/- S.E.M.). Somatostatin (2 mg per day) lowered glucagon to 60 +/- 13 pg per milliliter, glucose to 111 +/- 17 mg per deciliter, glucose excretion to 1 +/- 0.7 g per 24 hours, ketone excretion to 0.5 +/- 0.2 mmol per 24 hours and urea nitrogen excretion to 8 +/- 2 g per 24 hours. Replacement of glucagon raised glucagon to 272 +/- 30 pg per milliliter, glucose to 202 +/- 20 mg per deciliter, glucose excretion to 14 +/- 7 g per 24 hours, ketone excretion to 0.8 mmol per 24 hours and urea nitrogen excretion to 11 +/- 2 g per 24 hours. In a subsequent study, similar improvement occurred on a diet of 30 g of carbohydrate daily, when absorption of dietary glucose was negligible. Hyperglucagonemia has an important role in diabetes; its correction reduces diabetic abnormalities to or toward normal.

Citing Articles

Real-time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes.

Yang M, Mandal K, Sodergren M, Dumral O, Winroth L, Tengholm A Acta Physiol (Oxf). 2025; 241(2):e14268.

PMID: 39803760 PMC: 11726413. DOI: 10.1111/apha.14268.


A differentiation protocol for generating pancreatic delta cells from human pluripotent stem cells.

Zhang T, Wang N, Liao Z, Chen J, Meng H, Lin H Front Cell Dev Biol. 2024; 12:1490040.

PMID: 39493348 PMC: 11527672. DOI: 10.3389/fcell.2024.1490040.


The Inferential Binding Sites of GCGR for Small Molecules Using Protein Dynamic Conformations and Crystal Structures.

Wang M, Fu X, Du L, Shi F, Huang Z, Yang L Int J Mol Sci. 2024; 25(15).

PMID: 39125959 PMC: 11313378. DOI: 10.3390/ijms25158389.


Directed differentiation of pancreatic δ cells from human pluripotent stem cells.

Chen L, Wang N, Zhang T, Zhang F, Zhang W, Meng H Nat Commun. 2024; 15(1):6344.

PMID: 39068220 PMC: 11283558. DOI: 10.1038/s41467-024-50611-7.


Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.

Winther-Sorensen M, Garcia S, Bartholdy A, Ottenheijm M, Banasik K, Brunak S Diabetologia. 2024; 67(8):1602-1615.

PMID: 38705923 PMC: 11343844. DOI: 10.1007/s00125-024-06160-1.